نتایج جستجو برای: hiv 1 dna vaccine

تعداد نتایج: 3346593  

Journal: :BMJ 2002
Roy D Mugerwa Pontiano Kaleebu Peter Mugyenyi Edward Katongole-Mbidde David L Hom Rose Byaruhanga Robert A Salata Jerrold J Ellner

Trials of the HIV-1 vaccine have been conducted in Europe, North America, Brazil, China, and Thailand. The first trial of a candidate vaccine in Africa was recently completed in Uganda. It involved a randomised, placebo controlled trial of a vaccine in healthy volunteers at low risk of HIV infection. 3 The vaccine, called “ALVAC-HIV,” uses a live recombinant canarypox vector to express envelope...

2014
Paul F. McKay Alethea V. Cope Jamie F. S. Mann Sarah Joseph Mariano Esteban Roger Tatoud Darrick Carter Steven G. Reed Jonathan Weber Robin J. Shattock

Using a unique vaccine antigen matched and single HIV Clade C approach we have assessed the immunogenicity of a DNA-poxvirus-protein strategy in mice and rabbits, administering MVA and protein immunizations either sequentially or simultaneously and in the presence of a novel TLR4 adjuvant, GLA-AF. Mice were vaccinated with combinations of HIV env/gag-pol-nef plasmid DNA followed by MVA-C (HIV e...

Journal: :Annual Review of Medicine 2010

Journal: :Vaccines 2016
Chongbo Zhao Zhujun Ao Xiaojian Yao

HIV-1 virus-like particles (VLPs) are promising vaccine candidates against HIV-1 infection. They are capable of preserving the native conformation of HIV-1 antigens and priming CD4+ and CD8+ T cell responses efficiently via cross presentation by both major histocompatibility complex (MHC) class I and II molecules. Progress has been achieved in the preclinical research of HIV-1 VLPs as prophylac...

Journal: :The Journal of infectious diseases 2002
Mary A Marovich John R Mascola Michael A Eller Mark K Louder Pierre A Caudrelier Raphaelle El-Habib Silvia Ratto-Kim Josephine H Cox Jeffrey R Currier Bruce L Levine Carl H June Wendy B Bernstein Merlin L Robb Beatrice Schuler-Thurner Ralph M Steinman Deborah L Birx Sarah Schlesinger-Frankel

Preclinical data are reported that support a human immunodeficiency virus (HIV) vaccine strategy using recombinant canarypox-HIV vectors (ALVAC-HIV) to load human dendritic cells (DCs) with HIV antigens. Clinical-grade DCs were infected with good manufacturing practice-grade ALVAC-HIV vaccine constructs. ALVAC infection, HIV gene expression, and DC viability and function were monitored by use o...

Journal: :Vaccine 2005
Robert De Rose Socheata Chea C Jane Dale Jeanette Reece Caroline S Fernandez Kim M Wilson Scott Thomson Ian A Ramshaw Barbara E H Coupar David B Boyle Mark T Sullivan Stephen J Kent

To induce broad T cell immunity to HIV-1, we evaluated the safety, immunogenicity and dose-response relationship of DNA and recombinant Fowlpoxvirus (rFPV) vaccines encoding five shared HIV subtype AE genes (Gag, Pol, Env, Tat, Rev) in pigtail macaques. The DNA (three doses of either 1 mg or 4.5 mg) and rFPV (a single boost of either 5 x 10(7) or 2 x 10(8) plaque forming units) vaccines were ad...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید